F. Post

发表

Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir

L. Campbell, F. Ibrahim, B. Barbini, 2021, HIV medicine.

TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral Therapy

M. García-Fiñana, R. Kolamunnage-Dona, C. Leen, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Associations between widespread pain and sleep quality in people with HIV.

S. Redline, A. Winston, C. Sabin, 2020, Journal of acquired immune deficiency syndromes.

Antiretroviral Therapy in Advanced HIV-1 Infection

P. Easterbrook, F. Post, 2005, Journal of the International Association of Physicians in AIDS Care.

Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort study

M. Vizcaychipi, L. Campbell, F. Ibrahim, 2013, BMC Infectious Diseases.

CD4+ T-Cell Count at Antiretroviral Therapy Initiation in the “Treat-All” Era in Rural South Africa: An Interrupted Time Series Analysis

T. Bärnighausen, Jan‐Walter De Neve, D. Pillay, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluating the Impact of Functional Genetic Variation on HIV-1 Control

D. Goldstein, B. Walker, P. D. de Bakker, 2017, The Journal of infectious diseases.

Association between health-related quality of life and menopausal status and symptoms in women living with HIV aged 45–60 years in England: An analysis of the PRIME study

R. Gilson, C. Sabin, A. Miners, 2022, Women's health.

COVID‐19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID‐19 pandemic in England

C. Sabin, A. Sullivan, L. Waters, 2021, HIV medicine.

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

B. Gazzard, C. Leen, C. Sabin, 2011, BMJ : British Medical Journal.

During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ

D. Richman, A. Phillips, J. Ainsworth, 2015, EBioMedicine.

Biomarkers to Monitor Safety in People on ART and Risk of Mortality

B. Gazzard, C. Leen, C. Sabin, 2012, Journal of acquired immune deficiency syndromes.

Is 1 Alanine Transaminase >200 IU Enough to Define an Alanine Transaminase Flare in HIV-Infected Populations? A New Definition Derived From a Large Cohort Study

B. Gazzard, C. Leen, D. Pillay, 2009, Journal of acquired immune deficiency syndromes.

A systematic review of definitions of extreme phenotypes of HIV control and progression

D. Gurdasani, Louise Iles, E. Young, 2013, AIDS.

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

C. Brander, V. Miller, T. Peto, 2021, Cell reports.

Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV

A. Winston, C. Sabin, S. Khoo, 2021, PloS one.

Special Issue: British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (2013 update)

C. Leen, A. Winston, C. Sabin, 2014 .

British HIV Association guidelines for the management of tuberculosis in adults living with HIV 2019

C. Leen, K. Seden, S. Khoo, 2019, HIV medicine.

Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina

A. Mocroft, O. Kirk, N. Chentsova, 2009, AIDS.

Prevention of bone loss and management of fracture risk in HIV-infected individuals: case studies and recommendations for different patient subgroups

E. McCloskey, M. Johnson, J. Compston, 2011 .

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF in HIV-Infected Patients With Mild-to-Moderate Renal Impairment

F. Post, A. Cheng, C. Beraud, 2015, Journal of acquired immune deficiency syndromes.

Cobicistat-Boosted Protease Inhibitors in HIV-Infected Patients with Mild to Moderate Renal Impairment

F. Post, M. Ramgopal, M. Fisher, 2014, HIV clinical trials.

Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV

Hongbo Deng, A. Winston, C. Sabin, 2022, Kidney international reports.

HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico

M. Lederman, D. Podzamczer, D. Kuritzkes, 2015, Journal of the International AIDS Society.

Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV

Hongbo Deng, A. Winston, C. Sabin, 2021, Kidney international reports.

Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe.

A. Mocroft, O. Kirk, N. Chentsova, 2014, The Journal of infection.

HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.

Scott E. Smith, I. Lossos, S. Montoto, 2021, Blood advances.

Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

B. Gazzard, I. Williams, A. Winston, 2012, JAMA.

Short Communication: The Impact of Switching from Atripla to Darunavir/Ritonavir Monotherapy on Neurocognition, Quality of Life, and Sleep: Results from a Randomized Controlled Study.

J. Fox, F. Post, R. Kulasegaram, 2016, AIDS research and human retroviruses.

Survival of human immunodeficiency virus-infected persons with pulmonary tuberculosis.

R. Wood, F. Post, 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Spectrum of chronic kidney disease in HIV‐infected patients

B. Hendry, L. Campbell, F. Ibrahim, 2009, HIV medicine.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

P. Easterbrook, H. Namata, A. Siika, 2018, The Lancet. Infectious diseases.

Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial.

D. Podzamczer, A. Winston, M. Das, 2018, The lancet. HIV.

Menopausal status, age and management among women living with HIV in the UK

R. Gilson, C. Sabin, A. Sullivan, 2021, HIV medicine.

Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity

G. Kaplan, A. Moreira, L. Bekker, 2003, Infection and Immunity.

The Association between Detected drug Resistance Mutations and CD4+ T-Cell Decline in HIV-Positive Individuals Maintained on a Failing Treatment Regimen

O. Kirk, A. Schultze, R. Paredes, 2018, Antiviral therapy.

Pulmonary tuberculosis in HIV infection: radiographic appearance is related to CD4+ T-lymphocyte count.

R. Wood, F. Post, G. Pillay, 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Anaesthesia and intensive care in patients with HIV

M. Vizcaychipi, F. Post, J. Shrosbree, 2011 .

Response to the communication of M Hosp et al. on low‐cost progression markers in HIV‐1 seropositive Zambians

G. Maartens, R. Wood, F. Post, 2001, HIV medicine.

Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?

B. Gazzard, C. Leen, C. Sabin, 2009, AIDS.

AIDS in Africa--survival according to AIDS-defining illness.

G. Maartens, R. Wood, F. Post, 2001, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro.

G. Kaplan, B. Ryffel, N. Connell, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Tubercle and Lung Disease

F. Post, R. Wood, G. Pillay, 1995 .

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 96‐week results from two randomized clinical trials†

H. Stellbrink, M. Das, E. Daar, 2018, HIV medicine.

Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients

B. Hendry, L. Campbell, F. Ibrahim, 2012, BMC Nephrology.

Renal Impairment Is Associated With Coronary Heart Disease in HIV-Positive Men

L. Campbell, F. Ibrahim, J. Fox, 2012, HIV clinical trials.

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America

A. Mocroft, O. Kirk, A. Schultze, 2014, Journal of the International AIDS Society.

HIV infection is not associated with an increased rate of drug-resistant tuberculosis.

R. Wood, F. Post, 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The renal-bone axis in older people living with HIV on stable antiretroviral therapy: A sub-analysis of the GS-US-104-0423 study

W. Tinago, F. Jouret, L. Campbell, 2022, Antiviral therapy.

Bone mineral density decline in patients on stable antiretroviral therapy.

F. Post, 2017, AIDS.

Managing chronic kidney disease in the older adults living with HIV

F. Post, 2016, Current opinion in infectious diseases.

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

P. Easterbrook, T. Peto, N. French, 2017, The lancet. HIV.

Respiratory symptoms and chronic bronchitis in people with and without HIV infection

A. Winston, C. Sabin, F. Post, 2020, HIV medicine.

Abacavir and increased risk of myocardial infarction

L. Campbell, F. Post, 2008, The Lancet.

Association between health-related quality of life and menopausal status and symptoms in women living with HIV aged 45–60 years in England: An analysis of the PRIME study and Women’s Where Are We Now

R. Gilson, C. Sabin, A. Miners, 2022 .

Total lymphocyte count as a surrogate for CD4+ lymphocyte count in African patients coinfected with HIV and tuberculosis.

R. Wood, F. Post, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

S. Norton, E. Lioudaki, F. Post, 2021 .

HIV and the kidney: a UK perspective.

F. Post, E. Mabonga, E. Cheserem, 2014, British journal of hospital medicine.

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet Respiratory Medicine.

HIV‐associated central nervous system diseases in the recent combination antiretroviral therapy era

B. Gazzard, C. Leen, D. Pillay, 2011, European journal of neurology.

Contribution of vitamin D(2) to total vitamin D in HIV-positive patients.

L. Couchman, L. Campbell, F. Post, 2011, Journal of acquired immune deficiency syndromes.

Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individuals

A. Winston, C. Sabin, A. Milinkovic, 2019, International journal of STD & AIDS.

Weight Change Following Antiretroviral Therapy Switch in People with Viral Suppression: Pooled Data from Randomized Clinical Trials.

H. Stellbrink, P. Sax, J. Rockstroh, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Obesity and diabetes in people of African ancestry with HIV

David Hopkins, F. Post, C. Norcross, 2022, HIV medicine.

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia

C. Leen, M. Pirmohamed, L. Haddow, 2016, Journal of NeuroVirology.

Do nevirapine and efavirenz affect vitamin D homeostasis similarly?

F. Post, K. Childs, T. Welz, 2011, AIDS.

Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy

C. Leen, C. Sabin, M. Johnson, 2014, AIDS.

Recent developments in HIV and the kidney

F. Post, S. Holt, 2009, Current opinion in infectious diseases.

Implementation of routine interferon-gamma release assay testing in a South London HIV cohort

F. Post, Robert F Miller, Chris Taylor, 2020, International journal of STD & AIDS.

AUDIT REPORT Implementation of routine IGRA testing in a South London HIV cohort

F. Post, Robert F Miller, Chris Taylor, 2020 .

Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series

F. Post, K. Childs, T. Juniper, 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

HIV-associated kidney disease in the context of an aging population.

F. Post, L. Hamzah, C. Naftalin, 2011, Sexual health.

HIV and kidney disease

F. Post, L. Hamzah, 2009 .

CD4 and total lymphocyte counts as predictors of HIV disease progression.

G. Maartens, R. Wood, F. Post, 1996, QJM : monthly journal of the Association of Physicians.

Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

M. Das, A. Clarke, P. Tebas, 2017, Journal of acquired immune deficiency syndromes.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

K. Lichtenstein, F. Post, Samir K. Gupta, 2016, Journal of acquired immune deficiency syndromes.

Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patients

L. Campbell, A. Samarawickrama, Y. Gilleece, 2015, AIDS.

End-Stage Kidney Disease and Kidney Transplantation in HIV-Positive Patients: An Observational Cohort Study

C. Leen, C. Sabin, M. Johnson, 2014, Journal of acquired immune deficiency syndromes.

Polymorphisms of tenofovir disoproxil fumarate transporters and risk of kidney tubular dysfunction in HIV-positive patients: genetics of tenofovir transporters

S. Khoo, F. Post, M. Danjuma, 2018, International journal of STD & AIDS.

Effects on Vitamin D, Bone and the Kidney of Switching from Fixed-Dose Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz to Darunavir/ Ritonavir Monotherapy: A Randomized, Controlled Trial (MIDAS)

F. Ibrahim, J. Fox, F. Post, 2015, Antiviral therapy.

Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate.

C. Sabin, B. Hendry, F. Post, 2017, The Journal of infection.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

J. Seeley, A. Walker, N. Klein, 2018 .

L. Campbell, F. Post, L. Hamzah, 2011, Journal of acquired immune deficiency syndromes.

Predicting virological decay in patients starting combination antiretroviral therapy

J. Sterne, C. Leen, R. Gilson, 2016, AIDS.

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015

C. Leen, A. Winston, C. Sabin, 2016, HIV medicine.

British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)

C. Leen, A. Winston, C. Sabin, 2014, HIV medicine.

7.0 Managing virological failure

C. Leen, A. Winston, C. Sabin, 2012, HIV medicine.

Pain in people living with HIV and its association with healthcare resource use, well being and functional status

A. Winston, C. Sabin, M. Johnson, 2018, AIDS.

Defining cognitive impairment in people-living-with-HIV: the POPPY study

A. Winston, C. Sabin, J. Underwood, 2016, BMC Infectious Diseases.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Cervical cancer risk in women living with HIV across four continents: A multicohort study

Richard D Moore, J. Goedert, S. Franceschi, 2020, International journal of cancer.

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Anne M Johnson, Hansjakob Furrer, Peter Reiss, 2013, PLoS medicine.

HIV-1 infection and the kidney: an evolving challenge in HIV medicine.

F. Post, T. D. de Silva, M. Griffin, 2007, Mayo Clinic proceedings.

Use of β-D-glucan in diagnosis of suspected Pneumocystis jirovecii pneumonia in adults with HIV infection

F. Post, R. Gorton, Eliza Gil, 2021, International journal of STD & AIDS.

Cerebral toxoplasmosis in a middle-aged man as first presentation of primary immunodeficiency due to a hypomorphic mutation in the CD40 ligand gene

P. Easterbrook, F. Post, K. Gilmour, 2008, Journal of Clinical Pathology.

Renal tubular disease in the era of combination antiretroviral therapy

C. Sabin, F. Post, R. Hilton, 2015, AIDS.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

D. Podzamczer, P. Sax, M. Saag, 2015, The Lancet.

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

H. Stellbrink, P. Sax, J. Rockstroh, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy: A Randomized Phase 2 Study

P. Sax, A. Zolopa, F. Post, 2014, Journal of acquired immune deficiency syndromes.

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TA

C. Orkin, F. Post, S. De Wit, 2019, Antiviral research.

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV

B. Gazzard, C. Leen, C. Fraser, 2019, Journal of virus eradication.

Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression

C. Leen, C. Sabin, A. Phillips, 2014, AIDS.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

Kholoud Porter, John Walsh, Martin Fisher, 2014, AIDS.

KIDNEY DISEASE IN THE SETTING OF HIV INFECTION: CONCLUSIONS FROM A KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CONTROVERSIES CONFERENCE

C. Winkler, V. D’Agati, D. Wheeler, 2018, Nephrology (Saint-Petersburg).

Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

C. Winkler, V. D’Agati, D. Wheeler, 2018, Kidney international.

Improving Global Outcomes ( KDIGO ) Kidney disease in the setting of HIV infection : conclusions from a Kidney Disease : Controversies Conference

C. Winkler, V. D’Agati, D. Wheeler, 2018 .

Tenofovir disoproxil fumarate-associated bone loss: does vitamin D-binding protein play a role?

J. Fox, F. Post, L. Hamzah, 2017, AIDS.

Renal health after long-term exposure to tenofovir disoproxil fumarate (TDF) in HIV/HBV positive adults in Ghana.

F. Post, F. Sarfo, A. Geretti, 2018, The Journal of infection.

Protease Inhibitors

F. Post, V. Anton-Vazquez, 2021, Encyclopedia of Virology.

Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase

F. Ibrahim, F. Post, K. Childs, 2010, AIDS.

Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure

C. Sabin, B. Hendry, L. Campbell, 2010, AIDS.

P029: Safety of tenofovir alafenamide in renal impairment

K. Lichtenstein, F. Post, Samir K. Gupta, 2015 .

Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1–Infected Adults: 48-Week Results From the ASSERT Study

D. Podzamczer, H. Stellbrink, A. Rieger, 2010, Journal of acquired immune deficiency syndromes.

Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients

A. Samarawickrama, F. Post, K. Childs, 2012, AIDS.

Integration of High-Throughput Imaging and Multiparametric Metabolic Profiling Reveals a Mitochondrial Mechanism of Tenofovir Toxicity

F. Post, B. Payne, A. Sachdeva, 2022, Function.

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

HIV and the kidney.

B. Hendry, F. Post, 2008, British journal of hospital medicine.

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet. Microbe.

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America

A. Mocroft, O. Kirk, A. Schultze, 2018, BMC Infectious Diseases.

TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality

A. Mocroft, O. Kirk, H. Furrer, 2013, BioMed research international.

Biomarkers of impaired renal function

A. Mocroft, F. Post, C. Wyatt, 2010, Current opinion in HIV and AIDS.

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir

C. Sabin, A. Phillips, F. Post, 2017, AIDS.

HIV Drug Therapy in the Americas Congress, 13 – 15 June 2013, São Paulo, Brazil

M. Lederman, D. Kuritzkes, K. White, 2013, Journal of the International AIDS Society.

Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

M. Johnson, V. Miller, T. Peto, 2020, The Lancet.

S. Norton, E. Lioudaki, F. Post, 2021, BMC Nephrology.

A Continuous Quality Improvement Intervention to Improve Antenatal HIV Care Testing in Rural South Africa: Evaluation of Implementation in a Real-World Setting

S. Wyke, T. Bärnighausen, Jan‐Walter De Neve, 2020, International journal of health policy and management.

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study

C. Leen, D. Pillay, R. Gilson, 2017, The lancet. HIV.

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

Panteleimon G. Takis, Jordan J. Clark, Michael J. Murphy, 2021, The Lancet.

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

J. Seeley, K. Maitland, A. Shali, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outcomes in the First Year after Initiation of First-Line Haart among Heterosexual Men and Women in the Uk Chic Study

B. Gazzard, C. Leen, D. Pillay, 2011, Antiviral therapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Mortality and AIDS‐defining events among young people following transition from paediatric to adult HIV care in the UK

A. Winston, C. Sabin, F. Post, 2021, HIV medicine.

A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study

C. Leen, D. Pillay, C. Sabin, 2018, The lancet. HIV.

Factors associated with obesity in the Pharmacokinetic and Clinical Observations in People over Fifty (POPPY) cohort: an observational cross‐sectional analysis

A. Winston, C. Sabin, D. De Francesco, 2020, HIV medicine.

The association between severe menopausal symptoms and engagement with HIV care and treatment in women living with HIV

C. Sabin, J. Fox, Y. Gilleece, 2020, AIDS care.

Cohort profile: The Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study.

A. Winston, C. Sabin, M. Johnson, 2018, International journal of epidemiology.

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure

C. Leen, D. Pillay, R. Gilson, 2014, The Journal of infectious diseases.

HIV care and the incidence of acute renal failure.

B. Hendry, L. Campbell, F. Ibrahim, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Development and application of a new measure of engagement in out‐patient HIV care

B. Gazzard, C. Leen, D. Pillay, 2016, HIV Medicine.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Feasibility randomized‐controlled trial of online acceptance and commitment therapy for painful peripheral neuropathy in people living with HIV: The OPEN study

S. Norton, A. Rice, L. Campbell, 2021, European journal of pain.

Infant feeding knowledge and practice vary by maternal HIV status: a nested cohort study in rural South Africa

T. Bärnighausen, Jan‐Walter De Neve, D. Pillay, 2020, International Breastfeeding Journal.

Pituitary function after selective adenomectomy for Cushing's disease.

F. Post, N. Levitt, S. Soule, 1995, British journal of neurosurgery.

Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort study.

Y. Takwoingi, J. Deeks, G. Cooke, 2019, The Lancet. Infectious diseases.

A. Mocroft, O. Kirk, A. Schultze, 2016, The lancet. HIV.

Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America

A. Mocroft, O. Kirk, A. Schultze, 2015, PLoS ONE.

Predictors of renal outcome in HIV-associated nephropathy.

P. Easterbrook, B. Hendry, J. Ainsworth, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kidney transplantation in HIV-positive adults: the UK experience

S. Khoo, F. Post, S. Bhagani, 2014, International journal of STD & AIDS.

Clinical characteristics and outcomes of HIV-associated immune complex kidney disease.

C. Sabin, B. Hendry, F. Post, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

H. Jessen, R. Grant, K. Mounzer, 2020, The Lancet.

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.

Anne M Johnson, A. Mocroft, O. Kirk, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Uptake and Outcome of Combination Antiretroviral Therapy in Men Who Have Sex with Men According to Ethnic Group: The UK CHIC Study

B. Gazzard, C. Leen, C. Sabin, 2011, Journal of acquired immune deficiency syndromes.

Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity

S. Khoo, F. Post, J. Levy, 2014, AIDS.

Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus–Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus–Uninfected Controls

P. Reiss, F. Wit, M. Prins, 2017, The Journal of infectious diseases.

The epidemiology of kidney disease in people of African ancestry with HIV in the UK

C. Winkler, C. Sabin, A. Clarke, 2021, EClinicalMedicine.

The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial

S. Wyke, T. Bärnighausen, Jan‐Walter De Neve, 2020, PLoS Medicine.

Host factors predisposing to kidney disease in people with HIV.

F. Post, R. Hung, C. Winkler, 2022, Current opinion in HIV and AIDS.

Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B

F. Post, N. Patel, 2021, International journal of STD & AIDS.

Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.

J. Fox, F. Post, K. Childs, 2021, AIDS.

The predictors of pain extent in people living with HIV.

A. Winston, C. Sabin, M. Johnson, 2020, AIDS.

A multidrug-resistant, acr1-deficient clinical isolate of Mycobacterium tuberculosis is unimpaired for replication in macrophages.

G. Kaplan, L. Bekker, Juliano Timm, 2006, Journal of Infectious Diseases.

Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensus.

C. Sabin, J. Lundgren, A. Sullivan, 2023, The lancet. HIV.

Sleep health and cognitive function among people with and without HIV: the use of different machine learning approaches

S. Redline, M. Rueschman, L. Haddow, 2021, Sleep.

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

D. Podzamczer, E. Negredo, H. Stellbrink, 2019, AIDS.

Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3

A. Lazzarin, Y. Yazdanpanah, F. Post, 2017, HIV clinical trials.

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet Rheumatology.

Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus–Positive Kidney Transplant Recipients

F. Post, S. Bhagani, J. Levy, 2016, Transplantation.

HIV and the kidney in the acute medical unit.

F. Post, J. Booth, 2015, Clinical medicine.

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans

M. Ritchie, D. Haas, G. Maartens, 2023, Pharmacogenetics and genomics.

Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure

Anne M Johnson, D. Hawkins, A. Phillips, 2013, PloS one.

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

P. Easterbrook, N. French, H. Namata, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study.

A. LaMarca, H. Stellbrink, F. Post, 2017, The lancet. HIV.

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals

B. Clotet, C. Katlama, A. Phillips, 2008, AIDS.

Mycobacterium tuberculosis 19-Kilodalton Lipoprotein Inhibits Mycobacterium smegmatis-Induced Cytokine Production by Human Macrophages In Vitro

G. Kaplan, B. Ryffel, F. Post, 2001, Infection and Immunity.

Risk factors and impact of patterns of co-occurring comorbidities in people living with HIV.

A. Winston, C. Sabin, M. Johnson, 2019, AIDS (London).

Level of agreement between frequently used cardiovascular risk calculators in people living with HIV

A. Winston, C. Sabin, M. Youle, 2019, HIV medicine.

Sleep Disorders in Human Immunodeficiency Virus: A Substudy of the Pharmacokinetics and Clinical Observations in People Over Fifty (POPPY) Study.

S. Redline, L. Haddow, A. Winston, 2020, Open forum infectious diseases.

Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients

Gilla Kaplan, Riccardo Manganelli, G. Kaplan, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Hospitalized patients with COVID-19 and HIV: a case series.

F. Post, K. Childs, T. Juniper, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Jordan J. Clark, Michael J. Murphy, Megan L. Nagel, 2021, The Lancet. Respiratory medicine.

Alemtuzumab induction therapy in HIV-positive renal transplant recipients.

F. Post, Rachael Jones, S. Kinloch, 2017, AIDS.

Kidney transplant outcomes in HIV serodiscordant recipient pairs.

F. Post, Sapna Shah, E. Gathogo, 2017, AIDS.

Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients.

C. Sabin, F. Ibrahim, F. Post, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Changes in multimorbidity burden over a 3–5 year period among people with HIV

A. Winston, C. Sabin, D. De Francesco, 2023, Frontiers in Systems Biology.

BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022

C. Leen, A. Winston, C. Sabin, 2022, HIV medicine.

Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals

A. Winston, S. Khoo, A. Clarke, 2018, AIDS.

CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF☆

C. Leen, M. Pirmohamed, L. Haddow, 2016, Cytokine.

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation

B. Gazzard, D. Webster, C. Leen, 2015, HIV medicine.

Cerebrospinal Fluid Viral Escape and Acute Encephalitis in a Patient on Boosted Protease Inhibitor Monotherapy

A. Siddiqui, J. Fox, F. Post, 2016, Antiviral therapy.

Changes in kidney function in patients with suppressed HIV RNA who substitute their protease inhibitor with atazanavir/ritonavir.

L. Campbell, F. Post, B. Engler, 2015, AIDS.

Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?

B. Gazzard, C. Leen, D. Pillay, 2012, The Journal of infectious diseases.

Cause of death among HIV patients in London in 2016

A. Sullivan, R. Miller, F. Post, 2019, HIV medicine.

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance

C. Leen, C. Fraser, E. Volz, 2018, The Journal of antimicrobial chemotherapy.

Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients

C. Sabin, F. Ibrahim, F. Post, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effect of menopause on weight gain, insulin and waist circumference in women with HIV who switch antiretroviral therapy to abacavir/lamivudine/dolutegravir.

F. Post, L. Hamzah, 2021, AIDS.

High‐risk behaviours, and their associations with mental health, adherence to antiretroviral therapy and HIV parameters, in HIV‐positive men who have sex with men

A. Winston, C. Sabin, F. Post, 2018, HIV Medicine.

Correlation between computerised and standard cognitive testing in people with HIV and HIV-negative individuals

L. Haddow, A. Winston, C. Sabin, 2020, AIDS care.

Depression, lifestyle factors and cognitive function in people living with HIV and comparable HIV‐negative controls

A. Winston, C. Sabin, J. Underwood, 2019, HIV medicine.

A Biopsychosocial Approach to HIV Fatigue: A Cross-Sectional and Prospective Analysis to Identify Key Modifiable Factors

T. Chalder, L. Campbell, F. Post, 2020, Behavioral medicine.

Clinical epidemiology of HIV-associated end-stage renal failure in the UK

C. Leen, C. Sabin, B. Hendry, 2009, AIDS.

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe

A. Mocroft, O. Kirk, H. Furrer, 2013, European Respiratory Journal.

Optimizing antiretroviral regimens in chronic kidney disease

F. Post, Rachael Jones, L. Hamzah, 2019, Current opinion in infectious diseases.

Creatinine and cystatin C-based estimated glomerular filtration rate estimates of kidney function in Black people with HIV on antiretroviral therapy

L. Campbell, F. Post, K. Bramham, 2022, AIDS.

Article Commentary: Correcting eGFR for the Effects of ART on Tubular Creatinine Secretion: Does One Size Fit All?

F. Post, L. Hamzah, 2020, Antiviral therapy.

Polypharmacy and Drug–drug Interactions in Older and Younger People Living with HIV: The POPPY Study

A. Winston, C. Sabin, F. Post, 2019, Antiviral therapy.

Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis.

G. Kaplan, E. Graviss, F. Post, 2004, The Journal of infectious diseases.

Agreement between self-reported and objective measures of sleep in people with HIV and lifestyle-similar HIV-negative individuals

S. Redline, L. Haddow, A. Winston, 2021, AIDS.

The Evolving Spectrum of Kidney Histology in HIV-Positive Patients in South Africa

F. Post, K. Manning, B. Rayner, 2023, Kidney international reports.

Tenofovir disoproxil and renal mitochondrial toxicity: more studies in Africans are needed.

F. Post, P. Sinxadi, 2022, AIDS.

Kidney disease in Africans with HIV and tuberculosis

F. Ibrahim, F. Post, S. Lucas, 2019, AIDS.

Plasma NRTI concentration and their associations with liver and renal parameters in people living with HIV.

A. Winston, C. Sabin, S. Khoo, 2020, AIDS (London).

Effects of age on antiretroviral plasma drug concentration in HIV-infected subjects undergoing routine therapeutic drug monitoring.

B. Gazzard, C. Leen, A. Winston, 2013, The Journal of antimicrobial chemotherapy.

Chronic Kidney Disease Risk in African and Caribbean Populations With HIV

B. Gazzard, C. Leen, D. Pillay, 2018, The Journal of infectious diseases.

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

B. Gazzard, D. Webster, C. Leen, 2013, The Journal of antimicrobial chemotherapy.

Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors

L. Waters, F. Post, J. Bayley, 2013, Infectious Diseases and Therapy.

Comorbidity indices in people with HIV and considerations for coronavirus disease 2019 outcomes

A. Winston, C. Sabin, D. De Francesco, 2020, AIDS.

Association of HIV status with sexual function in women aged 45–60 in England: results from two national surveys

C. Mercer, C. Sabin, A. Sullivan, 2019, AIDS care.

Comorbidity Indices in People with HIV and Considerations for COVID-19 Outcomes

A. Winston, C. Sabin, F. Post, 2020 .

British HIV Association guidelines for the routine investigation and monitoring of adult HIV‐1‐infected individuals 2011

C. Sabin, P. Cane, C. Orkin, 2012, HIV medicine.

Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach

E. McCloskey, L. Power, A. Phillips, 2013, HIV medicine.

Association between inflammatory biomarker profiles and cardiovascular risk in individuals with and without HIV

L. Haddow, A. Winston, C. Sabin, 2022, AIDS.

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.

A. Mocroft, O. Kirk, A. Schultze, 2018, The Journal of infection.

Follicle‐stimulating hormone in postmenopausal women living with HIV: a prevalence study

R. Gilson, C. Sabin, A. Sullivan, 2021, HIV medicine.

Monitoring of kidney function in HIV‐positive patients

R. Jones, F. Post, J. Yombi, 2015, HIV medicine.

Anticholinergic medications associated with falls and frailty in people with HIV

A. Winston, C. Sabin, F. Post, 2023, HIV medicine.

HbA1c screening for diabetes mellitus and to evaluate diabetic control in people of African ancestry with HIV in South London

L. Campbell, F. Post, L. Goff, 2023, International journal of STD & AIDS.

Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapy.

C. Leen, A. Winston, C. Sabin, 2015, The Journal of allergy and clinical immunology.

Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe

A. Mocroft, O. Kirk, J. Lundgren, 2015, HIV medicine.

Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.

A. Mocroft, O. Kirk, H. Furrer, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate

A. Winston, L. Campbell, B. Barbini, 2021, Journal of acquired immune deficiency syndromes.

Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

C. Winkler, V. D’Agati, D. Wheeler, 2018, Kidney international.

The impact of HIV drug resistance testing on changes to treatment

B. Gazzard, C. Sabin, A. Phillips, 2011, AIDS.

Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses

C. Brander, V. Miller, T. Peto, 2020, SSRN Electronic Journal.

Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity

S. Khoo, F. Post, J. Levy, 2014, AIDS.

Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG

L. Campbell, F. Ibrahim, B. Barbini, 2020, HIV medicine.